These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 20680712)
1. Prognostic impact of ERβ and MMP7 expression on overall survival in colon cancer. Fang YJ; Lu ZH; Wang F; Wu XJ; Li LR; Zhang LY; Pan ZZ; Wan DS Tumour Biol; 2010 Dec; 31(6):651-8. PubMed ID: 20680712 [TBL] [Abstract][Full Text] [Related]
2. Different effects of ERβ and TROP2 expression in Chinese patients with early-stage colon cancer. Fang YJ; Wang GQ; Lu ZH; Zhang L; Li JB; Wu XJ; Ding PR; Ou QJ; Zhang MF; Jiang W; Pan ZZ; Wan DS Tumour Biol; 2012 Dec; 33(6):2227-35. PubMed ID: 23055188 [TBL] [Abstract][Full Text] [Related]
3. Impact of ERβ and CD44 expression on the prognosis of patients with stage II colon cancer. Fang YJ; Zhang L; Wu XJ; Lu ZH; Li JB; Ou QJ; Zhang MF; Ding PR; Pan ZZ; Wan DS Tumour Biol; 2012 Dec; 33(6):1907-14. PubMed ID: 22836803 [TBL] [Abstract][Full Text] [Related]
4. Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer. Fang YJ; Lu ZH; Wang GQ; Pan ZZ; Zhou ZW; Yun JP; Zhang MF; Wan DS Int J Colorectal Dis; 2009 Aug; 24(8):875-84. PubMed ID: 19421758 [TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase 7 is a useful marker for 5-fluorouracil-based adjuvant chemotherapy in stage II and stage III colorectal cancer patients. Huang Y; Yu H; Lei H; Xie C; Zhong Y Med Oncol; 2014 Mar; 31(3):824. PubMed ID: 24469951 [TBL] [Abstract][Full Text] [Related]
6. Expression of voltage-gated sodium channel Nav1.5 in non-metastatic colon cancer and its associations with estrogen receptor (ER)-β expression and clinical outcomes. Peng J; Ou Q; Wu X; Zhang R; Zhao Q; Jiang W; Lu Z; Wan D; Pan Z; Fang Y Chin J Cancer; 2017 Nov; 36(1):89. PubMed ID: 29122010 [TBL] [Abstract][Full Text] [Related]
7. Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients. Klupp F; Neumann L; Kahlert C; Diers J; Halama N; Franz C; Schmidt T; Koch M; Weitz J; Schneider M; Ulrich A BMC Cancer; 2016 Jul; 16():494. PubMed ID: 27431388 [TBL] [Abstract][Full Text] [Related]
8. MMP7 expression regulated by endocrine therapy in ERbeta-positive colon cancer cells. Fang YJ; Pan ZZ; Li LR; Lu ZH; Zhang LY; Wan DS J Exp Clin Cancer Res; 2009 Sep; 28(1):132. PubMed ID: 19785773 [TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase-9 overexpression is closely related to poor prognosis in patients with colon cancer. Yang B; Tang F; Zhang B; Zhao Y; Feng J; Rao Z World J Surg Oncol; 2014 Jan; 12():24. PubMed ID: 24476461 [TBL] [Abstract][Full Text] [Related]
10. Gender-related survival differences associated with polymorphic variants of estrogen receptor-β (ERβ) in patients with metastatic colon cancer. Press OA; Zhang W; Gordon MA; Yang D; Haiman CA; Azuma M; Iqbal S; Lenz HJ Pharmacogenomics J; 2011 Oct; 11(5):375-82. PubMed ID: 20548329 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma. Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312 [TBL] [Abstract][Full Text] [Related]
12. Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Konstantinopoulos PA; Kominea A; Vandoros G; Sykiotis GP; Andricopoulos P; Varakis I; Sotiropoulou-Bonikou G; Papavassiliou AG Eur J Cancer; 2003 Jun; 39(9):1251-8. PubMed ID: 12763213 [TBL] [Abstract][Full Text] [Related]
13. Prognostic and predictive potential molecular biomarkers in colon cancer. Nastase A; Pâslaru L; Niculescu AM; Ionescu M; Dumitraşcu T; Herlea V; Dima S; Gheorghe C; Lazar V; Popescu I Chirurgia (Bucur); 2011; 106(2):177-85. PubMed ID: 21696062 [TBL] [Abstract][Full Text] [Related]
14. [Expression and clinical significance of survivin and matrix metalloproteinase-7 in colon cancer]. Wang GQ; Lu ZH; Fang YJ; Chen G; Zhou ZW; Pan ZZ; Wan DS Ai Zheng; 2009 Sep; 28(9):945-9. PubMed ID: 19728912 [TBL] [Abstract][Full Text] [Related]
15. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Campbell-Thompson M; Lynch IJ; Bhardwaj B Cancer Res; 2001 Jan; 61(2):632-40. PubMed ID: 11212261 [TBL] [Abstract][Full Text] [Related]
16. Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy. Kim JE; Hong YS; Kim HJ; Kim KP; Lee JL; Park SJ; Lim SB; Park IJ; Kim CW; Yoon YS; Yu CS; Kim JC; Hoon KJ; Kim TW Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S630-7. PubMed ID: 26271397 [TBL] [Abstract][Full Text] [Related]
17. Farnesoid X receptor represses matrix metalloproteinase 7 expression, revealing this regulatory axis as a promising therapeutic target in colon cancer. Peng Z; Chen J; Drachenberg CB; Raufman JP; Xie G J Biol Chem; 2019 May; 294(21):8529-8542. PubMed ID: 30967475 [TBL] [Abstract][Full Text] [Related]
18. Integrin alpha3 expression as a prognostic factor in colon cancer: association with MRP-1/CD9 and KAI1/CD82. Hashida H; Takabayashi A; Tokuhara T; Taki T; Kondo K; Kohno N; Yamaoka Y; Miyake M Int J Cancer; 2002 Feb; 97(4):518-25. PubMed ID: 11802216 [TBL] [Abstract][Full Text] [Related]
19. Expression and Prognostic Value of Oestrogen Receptor Beta in Colorectal Cancer. Pérez-Ruiz E; Rueda A; Pérez L; Rivas-Ruiz F; Torres E; de Luque V; Álvarez M; Sevilla I; Redondo M; Padilla-Ruiz M; Alba E; Alonso L Pathol Oncol Res; 2018 Oct; 24(4):871-879. PubMed ID: 28889324 [TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor β expression induces changes in the microRNA pool in human colon cancer cells. Edvardsson K; Nguyen-Vu T; Kalasekar SM; Pontén F; Gustafsson JÅ; Williams C Carcinogenesis; 2013 Jul; 34(7):1431-41. PubMed ID: 23436804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]